|
BiOasis Enters into a License Agreement with Astellas Research Institute
|
2
|
BIOASIS TECHNOLOGIES INC
|
Apr 21, 2016 09:23PM
|
|
Re: Hedge Knight Capital Discussion
|
2
|
Resverlogix Corp.
|
May 26, 2019 09:12AM
|
|
Re: Zenith Upcoming Events
|
2
|
Zenith Epigenetics
|
Aug 29, 2016 10:30AM
|
|
Re: Adjudication
|
2
|
Resverlogix Corp.
|
Jan 30, 2019 07:19AM
|
|
Updates from RH
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 09, 2016 11:04AM
|
|
Re: My one-minute commercial for Apabetalone
|
2
|
Resverlogix Corp.
|
Sep 10, 2019 09:20PM
|
|
Notice of Meeting and Management Information Circular Posted
|
2
|
Resverlogix Corp.
|
Sep 26, 2019 08:26PM
|
|
Re: Zenith Announces Issuance of Patent for ZEN-3694 and Presentation Details at BIO International Convention
|
2
|
Zenith Epigenetics
|
Jun 05, 2017 09:09AM
|
|
Re: Countdown
|
2
|
Resverlogix Corp.
|
Jul 08, 2017 08:24PM
|
|
Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
|
2
|
Resverlogix Corp.
|
Jan 13, 2020 08:29AM
|
|
Re: Clinical Trials
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 02, 2017 04:22PM
|
|
Re: Value
|
2
|
Zenith Epigenetics
|
Aug 23, 2017 04:37PM
|
|
Re: Warrants
|
2
|
Resverlogix Corp.
|
Jul 31, 2019 05:34PM
|
|
Re: quesstion for the board,,,,
|
2
|
Resverlogix Corp.
|
Jan 06, 2017 02:14PM
|
|
Re: List of things that point to postive data.
|
2
|
Resverlogix Corp.
|
Mar 28, 2019 10:09PM
|
|
BIO Investor Forum
|
2
|
Resverlogix Corp.
|
Oct 01, 2017 07:58AM
|
|
Re: Apabetalone MOA diagram
|
2
|
Resverlogix Corp.
|
Sep 28, 2019 01:23PM
|
|
Re: H1 2020 Potential Events -- NFK goes Virtual
|
2
|
Resverlogix Corp.
|
Mar 10, 2020 04:53PM
|
|
Re: AGM - High Level Summary
|
2
|
Zenith Epigenetics
|
Jan 08, 2016 01:40PM
|
|
Re: Hepalink Anniversary - Apr 27
|
2
|
Resverlogix Corp.
|
Apr 27, 2016 12:34PM
|
